247
Views
13
CrossRef citations to date
0
Altmetric
Research Article

The C. elegans PRMT-3 possesses a type III protein arginine methyltransferase activity

, , , , &
Pages 168-172 | Received 11 Jan 2011, Accepted 14 Jan 2011, Published online: 08 Mar 2011
 

Abstract

Protein arginine methylation is a common post-translational modification in eukaryotes that is catalyzed by a family of the protein arginine methyltransferases (PRMTs). PRMTs are classified into three types: type I and type II add asymmetrically and symmetrically dimethyl groups to arginine, respectively, while type III adds solely monomethyl group to arginine. However, although the enzymatic activity of type I and type II PRMTs have been reported, the substrate specificity and the methylation activity of type III PRMTs still remains unknown. Here, we report the characterization of Caenorhabditis elegans PRMT-2 and PRMT-3, both of which are highly homologous to human PRMT7. We find that these two PRMTs can bind to S-adenosyl methionine (SAM), but only PRMT-3 has methyltransferase activity for histone H2A depending on its SAM-binding domain. Importantly, thin-layer chromatographic analysis demonstrates that PRMT-3 catalyzes the formation of monomethylated, but not dimethylated arginine. Our study thus identifies the first type III PRMT in C. elegans and provides a means to elucidate the physiological significance of arginine monomethylation in multicellular organisms.

Acknowledgements

We thank the Caenorhabditis Genetics Center for providing Bristol N2 wild-type. We also thank members of the Fukamizu laboratory for helpful discussions. This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (17054004 to A.F.), and Grants-in-Aid for Young Scientists (20780237 and 22688029 to H.D.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

Declaration of interest

The authors declare no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.